Pfizer Inc.

• A Study to Learn How Different Manufactured Products of the Study Medicine Called Ritlecitinib are Taken up Into the Blood in Healthy Adults… Ended
  2023-505603-23-00 Phase I (Other) 1 country
• ADME: A Study to Understand What the Body does to the Study Compound Called PF-07220060 When Taken by Healthy Adults. Ended
  2023-507074-40-00 Phase I (Other) 1 country
• A Phase 2 Multicenter Study to Evaluate PF-06823859 in Adult Participants With Active CLE or SLE With Cutaneous Manifestations Ended
  2023-503343-33-00 Phase II 2 countries HUMANISED IGG1K MONOCLONAL ANTIBODY AGAINST INTERFERON BETA
• A Sub Study to Learn About the Study Medication Called Etrasimod Tablets in a Hybrid Decentralized Clinical Trial Setting Ended
  2023-508119-22-00 Phase I (Other) 1 country
• A Study to Learn How Different Amounts of the Study Medicine Called PF-07293893 are Tolerated and Act in the Body of Healthy Adults. Ended
  2023-508171-36-00 Phase I (Other) 1 country
• A study to learn how PF-07817883 is taken up into the blood of healthy adults after taking tablets of study drug with varying ingredients Ended
  2023-506442-24-00 Phase I (Other) 1 country
• A Phase 2 Safety and Immunogenicity Study of a Monovalent Pneumococcal Conjugate Candidate in Healthy Toddlers Ended
  2023-505154-18-00 Phase II 2 countries PF-07831695; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DER…
• A Study to Learn if a Medicine That Reduces Stomach Acid Affects the Blood Level of Study Intervention Called Sisunatovir in Healthy Adults Ended
  2023-507116-12-00 Phase I (Other) 1 country
• A Study to Learn How Different Manufactured Products of the Study Medicine Called Sisunatovir are Taken Up Into the Blood When Taken on an E… Ended
  2023-505228-79-00 Phase I (Other) 1 country
• A Study to Learn About the Study Medication Called Etrasimod Mini Tablets, Including Its Taste, When Mixed With Applesauce, Chocolate Puddin… Ended
  2023-504411-32-00 Phase I (Other) 1 country ETRASIMOD ARGININE
• A Study to Estimate the Effect of Multiple Doses of Carbamazepine on the PK of Single Dose Vepdegestrant in Healthy Adult Participants Ended
  2023-505881-27-00 Phase I (Other) 1 country
• A Study to Learn About the Study Medicine Called PF-07293893 in Healthy Adults, and How Different Doses of Study Medicine are Tolerated and … Ended
  2023-504921-37-00 Phase I 1 country
• A Study to Learn About the Taste Profiles of Different Suspensions of Study Medicine Called PF-07923568 in Healthy Adult Participants Ended
  2023-504924-24-00 Phase I (Other) 1 country DENATONIUM BENZOATE; SISUNATOVIR
• A Phase 3 Study Investigating the Efficacy, Safety, and Tolerability of Ritlecitinib in Participants with Nonsegmental Vitiligo Ended
  2022-501668-16-00 Phase III 5 countries RITLECITINIB TOSILATE
• A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who are Healthy Volunteers Co-administered the Medicine Ro… Ended
  2023-503570-20-00 Phase I (Other) 1 country NIRMATRELVIR; RITONAVIR; ROSUVASTATIN CALCIUM
• A Phase 1b, 2-part, placebo-controlled study to evaluate the efficacy, safety, and PK of PF-07054894 in participants with mild to severe UC. Ended
  2022-501047-32-00 Phase I (Other) 2 countries
• A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF PONSEGROMAB IN PATIENT… Ended
  2023-510446-24-00 Phase II 4 countries PONSEGROMAB
• Phase 2 Study of Encorafenib and Binimetinib Plus Pembrolizumab in Participants With BRAF V600E/K Mutation-Positive Melanoma Who Progressed … Ended
  2023-509471-17-00 Phase II 5 countries
• A Phase 2 Study of the Effects of Ponsegromab on Health-Related Quality of Life and Safety in Patients With Heart Failure (GARDEN-TIMI 74) Ended
  2023-509747-27-00 Phase II 5 countries PONSEGROMAB
• A Phase 1 Study Evaluating Relative Bioavailability of Sprinkled Ritlecitinib in Applesauce, Yoghurt, and Strawberry Jam and Evaluating the … Ended
  2022-502872-22-00 Phase I (Other) 1 country RITLECITINIB TOSILATE
• C4951004 - BHV3000-406: A Phase 4, Randomized, Double-blind Placebo Controlled, Efficacy and Tolerability Trial of Rimegepant for the Acute … Ended
  2024-513269-37-00 Phase IV 10 countries RIMEGEPANT
• C4951012 - BHV3000-407: A Phase 4, Randomized, Double-blind, Placebo controlled Study to Evaluate the Efficacy and Tolerability of Rimegepan… Ended
  2024-513270-21-00 Phase IV 9 countries RIMEGEPANT
• Phase 3, Placebo-Controlled, Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Trial of a 6-Valent OspA-Based Lyme Disease… Ended
  2023-509105-72-00 Phase III 5 countries BORRELIA BURGDORFERI, SEROTYPE 1, OUTER SURFACE PROTEIN A FUSED VIA A LINKER TO …
• PHASE 1/2 STUDY TO EVALUATE PALBOCICLIB (IBRANCE®) IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE OR IN COMBINATION WITH TOPOTECAN AND CYCL… Ended
  2024-511975-14-00 Phase I/II 5 countries CYCLOPHOSPHAMIDE MONOHYDRATE; IRINOTECAN HYDROCHLORIDE TRIHYDRATE; PALBOCICLIB; …

Showing 121–144 of 155 trials